EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.01 USD | -0.68% |
|
+1.80% | +15.42% |
| 12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
| Apr. 25 | Transcript : Edwards Lifesciences Corporation, Q1 2024 Earnings Call, Apr 25, 2024 |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 44 M€ | +0.64% | - | |
| 2.34% | 18 M€ | +3.79% | - | |
| 2.13% | 6 M€ | 0.00% | - | |
| 1.17% | 226 M€ | +2.10% | - | |
| 1.17% | 25 M€ | -1.22% | - | |
| 1.17% | 26 M€ | -1.25% | - | |
| 1.11% | 16 M€ | -8.49% | ||
| 1.06% | 2 M€ | +6.77% | ||
| 0.97% | 1 M€ | +2.21% | - | |
| 0.94% | 4,592 M€ | +11.18% | ||
| 0.89% | 40 M€ | -.--% | ||
| 0.73% | 9 M€ | -.--% | - | |
| 0.52% | 1 M€ | +16.32% | ||
| 0.46% | 2 M€ | +20.44% | - | |
| 0.44% | 5 M€ | -72.95% | - | |
| 0.42% | 3,859 M€ | +18.82% | - | |
| 0.42% | 469 M€ | -2.05% | - | |
| 0.36% | 8 M€ | +2.44% | ||
| 0.36% | 2,510 M€ | +11.17% | ||
| 0.34% | 36 M€ | -.--% | ||
| 0.33% | 52 M€ | +5.22% | ||
| 0.33% | 26 M€ | +1.54% | - | |
| 0.30% | 717 M€ | +5.55% | ||
| 0.30% | 219 M€ | +17.17% | - | |
| 0.30% | 1,448 M€ | -.--% | - | |
| 0.25% | 277 M€ | -.--% | - | |
| 0.24% | 194 M€ | +5.65% | - | |
| 0.24% | 441 M€ | +9.41% | ||
| 0.24% | 330 M€ | -.--% | - | |
| 0.23% | 2 M€ | +14.69% | - | |
| 0.23% | 9 M€ | +2.34% | - | |
| 0.23% | 736 M€ | +6.09% | ||
| 0.21% | 276 M€ | +11.40% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-05-07
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
88.01
USD
Average target price
94.48
USD
Spread / Average Target
+7.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.42% | 52.98B | |
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.30% | 62.51B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B | |
| +6.63% | 26.94B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
